;

Auto Summaries - Clinical Trials and Similar Human Studies
Last updated: 2025 Apr 18
Total hit(s): 16433
S.No.
1
39794268
Controlling the COVID-19 pandemic through vaccination: a perspective from Indonesia.
N/A
Expert Rev Vaccines
2025 Dec
4.37
1
2
40205748
Convalescent plasma: is there still a role in the treatment of COVID-19?
N/A
Singapore Med J
2025 Apr 9
1.26
1
3
40244474
Correction to: Pediatric and adult patients with ME/CFS following COVID-19: A structured approach to diagnosis using the Munich Berlin Symptom Questionnaire (MBSQ).
N/A
Eur J Pediatr
2025 Apr 17
2.24
1
4
40216663
Correction: Vitamin D: a key player in COVID19 immunity and lessons from the pandemic to combat immuneevasive variants.
N/A
Inflammopharmacology
2025 Apr 12
7.3
1
5
40122247
Rapid spread of Candida auris in China after COVID-19.
N/A
J Infect
2025 Apr
5.1
1
6
39965480
COVID-19 study quantifying daily viral loads confirms throat samples are key to early diagnosis.
N/A
Diagn Microbiol Infect Dis
2025 Apr
2.33
1
7
40140097
Rapid clinical effects of convalescent plasma therapy in severe COVID-19 acute respiratory distress syndrome (ARDS).
N/A
Intensive Care Med
2025 Mar 26
8.61
1
8
40147588
An overview of data analysis approaches and biases in unveiling the impact of COVID 19 on melanoma diagnosis.
N/A
J Invest Dermatol
2025 Mar 25
1
9
40078101
Sandwich-type graphene electrochemical sensor for nucleic acid detection of SARS-CoV-2.
N/A
Acta Biochim Biophys Sin (Shanghai)
2025 Mar 12
1.96
1
10
39915267
Using SARS-CoV-2 nucleoprotein antibodies to detect (re)infection.
N/A
Epidemiol Infect
2025 Feb 7
2.01
1
11
39902844
A Case of Post-Acute Severe Acute Respiratory Syndrome Coronavirus 2-Induced Focal Nonconvulsive Status Epilepticus With Impairment of Consciousness Initially Diagnosed as Anxiety.
N/A
Clin Neuropharmacol
2025 Feb 5
1
12
40001344
Melanoma Diagnosis in the Post-COVID-19 Era: Return to "Normality" only in 2023 in 2 German Skin Tumour Centers.
N/A
Acta Derm Venereol
2025 Feb 25
3.01
1
13
39987727
Retraction notice to "Differential detection of SARS-CoV-2 variants and influenza A viruses utilizing a dual lateral flow strip based on colloidal gold-labeled monoclonal antibodies" [Int. J. Biol. Macromol. 280P4 (2024) 136067].
N/A
Int J Biol Macromol
2025 Feb 21
4.94
1
14
39882620
The diagnosis of SARS-CoV-2-related myocarditis requires confirmation by endomyocardial biopsy or autopsy.
N/A
Cardiol Young
2025 Feb
0.84
1
15
40171102
Whole-genome sequencing of SARS-CoV-2 from residual viral RNA present on positive rapid antigen test kits for genomic surveillance.
N/A
Western Pac Surveill Response J
2025 Jan-Mar
1
16
39774639
Publisher Correction: Novel metal-organic framework biosensing platform for detection of COVID-19 RNA.
N/A
Sci Rep
2025 Jan 7
4.12
1
17
39757926
Case-only analysis of routine surveillance data: detection of increased vaccine breakthrough infections with SARS-CoV-2 variants in Europe.
N/A
Epidemiol Infect
2025 Jan 6
2.01
1
18
39878529
Erratum for Guo et al., "Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis".
N/A
mBio
2025 Jan 29
6.5
1
19
39837351
Retraction of: Structural Insights of the SARS-CoV-2 Nucleocapsid Protein: Implications for the Inner-workings of Rapid Antigen Tests.
N/A
Microsc Microanal
2025 Jan 22
1
20
39821615
Angiogenic markers as prognostic tools in patients with COVID-19: CRACoV-HHS study.
N/A
Kardiol Pol
2025 Jan 17
1.68
1
21
39820783
ASO Visual Abstract: Prognosis of Patients with Breast Cancer Following Delayed Diagnosis During the COVID-19 Pandemic: A Real-World Cohort Study.
N/A
Ann Surg Oncol
2025 Jan 16
5.3
1
22
39743663
Time matters in therapeutic plasma exchange for improving outcomes in severe COVID-19.
N/A
Ther Apher Dial
2025 Jan 1
2.7
1
23
40193821
Retraction: Ensemble learning for multi-class COVID-19 detection from big data.
N/A
PLoS One
2025
2.87
1
24
39931686
Editorial: Multisystem inflammatory syndrome observed post-COVID-19: the role of natural products, medicinal plants and nutrients and the use of prediction tools supporting traditional forms of diagnosis.
N/A
Front Pharmacol
2025
3.86
1
25
39578122
Corrigendum to "Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19" [Int. Immunopharmacol. 100 (2021) 108127].
N/A
Int Immunopharmacol
2024 Dec 25
3.38
1